Żuchowska Karolina, Filipiak Wojciech
Department of Pharmacodynamics and Molecular Pharmacology, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-089 Bydgoszcz, Poland.
J Pharm Anal. 2024 Apr;14(4):100898. doi: 10.1016/j.jpha.2023.11.005. Epub 2023 Nov 28.
Pathogenic microorganisms produce numerous metabolites, including volatile organic compounds (VOCs). Monitoring these metabolites in biological matrices (e.g., urine, blood, or breath) can reveal the presence of specific microorganisms, enabling the early diagnosis of infections and the timely implementation of targeted therapy. However, complex matrices only contain trace levels of VOCs, and their constituent components can hinder determination of these compounds. Therefore, modern analytical techniques enabling the non-invasive identification and precise quantification of microbial VOCs are needed. In this paper, we discuss bacterial VOC analysis under conditions, in animal models and disease diagnosis in humans, including techniques for offline and online analysis in clinical settings. We also consider the advantages and limitations of novel microextraction techniques used to prepare biological samples for VOC analysis, in addition to reviewing current clinical studies on bacterial volatilomes that address inter-species interactions, the kinetics of VOC metabolism, and species- and drug-resistance specificity.
致病微生物会产生大量代谢产物,包括挥发性有机化合物(VOCs)。监测生物基质(如尿液、血液或呼出气体)中的这些代谢产物可以揭示特定微生物的存在,从而实现感染的早期诊断并及时实施靶向治疗。然而,复杂基质中仅含有痕量水平的VOCs,且其组成成分会妨碍这些化合物的测定。因此,需要能够对微生物VOCs进行非侵入式鉴定和精确定量的现代分析技术。在本文中,我们讨论了在动物模型及人类疾病诊断中的条件下细菌VOC分析,包括临床环境中的离线和在线分析技术。除了回顾当前关于细菌挥发组的临床研究,这些研究涉及种间相互作用、VOC代谢动力学以及物种和耐药特异性外,我们还考虑了用于制备生物样品进行VOC分析的新型微萃取技术的优缺点。